Literature DB >> 14056924

INDOMETHACIN: A NEW NON-STEROID ANTI-INFLAMMATORY AGENT.

F D HART, P L BOARDMAN.   

Abstract

Entities:  

Keywords:  ANALGESICS AND ANTIPYRETICS; ARTHRITIS, RHEUMATOID; GOUT; INDOLES; OSTEOARTHRITIS; SPONDYLITIS, ANKYLOSING

Mesh：

Substances：

Year:  1963        PMID： 14056924      PMCID： PMC1873102          DOI： 10.1136/bmj.2.5363.965

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  1 in total

1.  Measurement of digital swelling in rheumatoid arthritis.

Authors:  F D HART; C J M CLARK
Journal:  Lancet       Date:  1951-04-07       Impact factor: 79.321
  1 in total
  49 in total

1.  INDOMETHACIN IN RHEUMATIC DISEASES. A CONTROLLED CLINICAL TRIAL.

Authors:  J WANKA; L I JONES; P H WOOD; A S DIXON
Journal:  Ann Rheum Dis       Date:  1964-05       Impact factor: 19.103

2.  RHEUMATOID ARTHRITIS OF THE LUMBAR SPINE.

Authors:  J S LAWRENCE; J SHARP; J BALL; F BIER
Journal:  Ann Rheum Dis       Date:  1964-05       Impact factor: 19.103

3.  TREATMENT OF OSTEO-ARTHRITIS OF THE HIP WITH INDOMETHACIN. A CONTROLLED CLINICAL TRIAL.

Authors:  J WANKA; A S DIXON
Journal:  Ann Rheum Dis       Date:  1964-07       Impact factor: 19.103

4.  TO-DAY'S DRUGS. DRUGS IN THE TREATMENT OF GOUT.

Authors:  M BEARE
Journal:  Br Med J       Date:  1965-01-16

5.  ANALGESIC DRUGS FOR RHEUMATISM.

Authors:  M E SMITH; J GOUGH; O P GALPIN
Journal:  Br Med J       Date:  1963-11-23

6.  INDOMETHACIN.

Authors:  C R PENGELLY
Journal:  Br Med J       Date:  1965-05-22

7.  INDOMETHACIN: STUDIES OF ABSORPTION AND OF THE USE OF INDOMETHACIN SUPPOSITORIES.

Authors:  L P HOLT; C F HAWKINS
Journal:  Br Med J       Date:  1965-05-22

8.  Indomethacin in traumatic musculo-skeletal disorders.

Authors:  G J Pawlowski
Journal:  Can Fam Physician       Date:  1971-02       Impact factor: 3.275

9.  Activation of latent infection by indomethacin: a report of three cases.

Authors:  L Solomon
Journal:  Br Med J       Date:  1966-04-16

10.  Endothelin-1 shifts the mediator of bradykinin-induced relaxation from NO to H2 O2 in resistance arteries from patients with cardiovascular disease.

Authors:  Thomas M Leurgans; Maria Bloksgaard; Jonathan R Brewer; Luis A Bagatolli; Maise H Fredgart; Kristoffer Rosenstand; Maria L Hansen; Lars M Rasmussen; Akhmadjon Irmukhamedov; Jo Gr De Mey
Journal:  Br J Pharmacol       Date:  2016-04-06       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.